Cytogenomic aberrations in isolated multicystic dysplastic kidney in children.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
02 2022
Historique:
received: 18 12 2020
accepted: 07 03 2021
revised: 08 02 2021
pubmed: 2 4 2021
medline: 12 4 2022
entrez: 1 4 2021
Statut: ppublish

Résumé

Multicystic dysplastic kidney (MCDK) is a common form of congenital kidney anomaly. The cause of MCDK is unknown. We investigated whether MCDK in children is linked to cytogenomic aberrations. We conducted array comparative genomic hybridization (aCGH) in ten unrelated children with MCDK. The pattern of inheritance was determined by real-time PCR in patients and their biological parents. Pathogenic aberrations were detected in three patients: a deletion at 7p14.3 with a size of 2.07 Mb housing 12 genes, including BBS9 (Bardet-Biedl syndrome 9) and BMPER (BMP binding endothelial regulator); a duplication at 16p13.11p12.3 with a size of 3.28 Mb that included >20 genes; and monosomy X for a female patient. The deletion at 7p14.3 was inherited from the patient's father, while the duplication at 16p13.11p12.3 was derived from the patient's mother. Up to 30% of patients with MCDK possess cytogenomic aberrations. BBS9 and BMPER variants have been reported to result in cystic kidney dysplasia, suggesting a possible pathogenic function for the deletion at 7p14.3 in children with MCDK. The duplication at 16p13.11p12.3 was not reported previously to associate with MCDK. Both variations were inherited from parents, indicating hereditary contributions in MCDK. Thus, aCGH is an informative tool to unravel the pathogenic mechanisms of MCDK. Cytogenomic aberrations are common in children with MCDK. Cytogenomic aberrations are inherited from parents, indicating hereditary contributions in MCDK. aCGH is a valuable tool to reveal pathogenic mechanisms of MCDK.

Sections du résumé

BACKGROUND
Multicystic dysplastic kidney (MCDK) is a common form of congenital kidney anomaly. The cause of MCDK is unknown. We investigated whether MCDK in children is linked to cytogenomic aberrations.
METHODS
We conducted array comparative genomic hybridization (aCGH) in ten unrelated children with MCDK. The pattern of inheritance was determined by real-time PCR in patients and their biological parents.
RESULTS
Pathogenic aberrations were detected in three patients: a deletion at 7p14.3 with a size of 2.07 Mb housing 12 genes, including BBS9 (Bardet-Biedl syndrome 9) and BMPER (BMP binding endothelial regulator); a duplication at 16p13.11p12.3 with a size of 3.28 Mb that included >20 genes; and monosomy X for a female patient. The deletion at 7p14.3 was inherited from the patient's father, while the duplication at 16p13.11p12.3 was derived from the patient's mother.
CONCLUSIONS
Up to 30% of patients with MCDK possess cytogenomic aberrations. BBS9 and BMPER variants have been reported to result in cystic kidney dysplasia, suggesting a possible pathogenic function for the deletion at 7p14.3 in children with MCDK. The duplication at 16p13.11p12.3 was not reported previously to associate with MCDK. Both variations were inherited from parents, indicating hereditary contributions in MCDK. Thus, aCGH is an informative tool to unravel the pathogenic mechanisms of MCDK.
IMPACT
Cytogenomic aberrations are common in children with MCDK. Cytogenomic aberrations are inherited from parents, indicating hereditary contributions in MCDK. aCGH is a valuable tool to reveal pathogenic mechanisms of MCDK.

Identifiants

pubmed: 33790410
doi: 10.1038/s41390-021-01476-9
pii: 10.1038/s41390-021-01476-9
pmc: PMC8481348
mid: NIHMS1682267
doi:

Substances chimiques

BMPER protein, human 0
Carrier Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-664

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK071699
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Song, R. & Yosypiv, IV. Genetics of congenital anomalies of the kidney and urinary tract. Pediatr. Nephrol. 26, 353–364 (2011).
doi: 10.1007/s00467-010-1629-4
Verbitsky, M. et al. The copy number variation landscape of congenital anomalies of the kidney and urinary tract. Nat. Genet. 51, 117–127 (2019).
doi: 10.1038/s41588-018-0281-y
Schreuder, M. F., van Wijk, J. A. & Westland, R. Unilateral multicystic dysplastic kidney: a meta-analysis of observational studies on the incidence, associated urinary tract malformations and the contralateral kidney. Nephrol. Dial. Transplant. 24, 1810–1818 (2009).
doi: 10.1093/ndt/gfn777
Sarhan, O. et al. Multicystic dysplastic kidney: impact of imaging modality selection on the initial management and prognosis. J. Pediatr. Urol. 10, 645–649 (2014).
doi: 10.1016/j.jpurol.2014.03.004
Cussen, L. J. & Felson, B. The hydronephrotic type of unilateral congenital multicystic disease of the kidney. Semin. Roentgenol. 10, 113–123 (1975).
doi: 10.1016/0037-198X(75)90035-8
Kitagawa, H. et al. Early bladder wall changes after creation of obstructive uropathy in fetal lamb. Pediatr. Surg. Int. 22, 875–879 (2006).
doi: 10.1007/s00383-006-1755-z
Brugnara, M., Fanos, V., Franchini, M. & Zaffanello, M. TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med. Sci. Monit. 14, RA78–RA86 (2008).
pubmed: 18509286
Fletcher, J. et al. Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2. J. Am. Soc. Nephrol. 16, 2754–2761 (2005).
doi: 10.1681/ASN.2005030239
Hwang, D. Y. et al. Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int. 85, 1429–1433 (2014).
doi: 10.1038/ki.2013.508
Song, R. & Yosypiv I. V. Sequence variants in the renin-angiotensin system genes are associated with isolated multicystic dysplastic kidney in children. Pediatr. Res. https://doi.org/10.1038/s41390-020-01255-y (2020).
Sanna-Cherchi, S. et al. Copy-number disorders are a common cause of congenital kidney malformations. Am. J. Hum. Genet. 91, 987–997 (2012).
doi: 10.1016/j.ajhg.2012.10.007
Schwartz, G. J. & Work, D. F. Measurement and estimation of GFR in children and adolescents. J. Am. Soc. Nephrol. 4, 1832–1843 (2009).
doi: 10.2215/CJN.01640309
South, S. T. et al. For the Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet. Med. 15, 901–909 (2013).
Riggs, E. R. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet. Med. 22, 245–257 (2020).
doi: 10.1038/s41436-019-0686-8
Imhoff, O. et al. Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French Cohort. Clin. J. Am. Soc. Nephrol. 6, 22–29 (2011).
doi: 10.2215/CJN.03320410
Nishimura, D. Y. et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am. J. Hum. Genet. 77, 1021–1033 (2005).
doi: 10.1086/498323
Guo, D. F. et al. Inactivation of Bardet-Biedl syndrome genes causes kidney defects. Am. J. Physiol. Ren. Physiol. 300, F574–F580 (2011).
doi: 10.1152/ajprenal.00150.2010
Prefumo, F. et al. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests. Am. J. Med. Genet. 120A, 386–388 (2003).
doi: 10.1002/ajmg.a.20097
Zong, Z. et al. BMPER variants associated with a novel, attenuated subtype diaphanospondylodysostosis. J. Hum. Genet. 60, 743–747 (2015).
doi: 10.1038/jhg.2015.116
Fogo, A., Hogan, B. L., Ichikawa, I., Miyazaki, Y. & Oshima, K. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Investig. 105, 863–873 (2000).
doi: 10.1172/JCI8256
Michos, O. et al. Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signaling during kidney branching morphogenesis. Development 134, 2397–2405 (2007).
doi: 10.1242/dev.02861
Miyazaki, Y., Oshima, K., Fogo, A. & Ichikawa, I. Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int. 63, 835–844 (2003).
doi: 10.1046/j.1523-1755.2003.00834.x
Weber, S. et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J. Am. Soc. Nephrol. 19, 891–903 (2008).
doi: 10.1681/ASN.2006111282
Szabo, L. et al. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol. 16, 1–26 (2015).
doi: 10.1186/s13059-015-0690-5
An, Y., Furber, K. L. & Ji, S. Pseudogenes regulate parental gene expression via ceRNA network. J. Cell. Mol. Med. 21, 185–192 (2017).
doi: 10.1111/jcmm.12952
Duff, M. O. et al. Genome-wide identification of zero nucleotide recursive splicing in Drosophila. Nature 521, 376–379 (2015).
doi: 10.1038/nature14475

Auteurs

Tian-Jian Chen (TJ)

Section of Pediatric Nephrology, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA.
Hayward Genetic Center, Tulane University School of Medicine, New Orleans, LA, USA.

Renfang Song (R)

Section of Pediatric Nephrology, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA.

Adam Janssen (A)

Section of Pediatric Nephrology, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA.
Hayward Genetic Center, Tulane University School of Medicine, New Orleans, LA, USA.

Ihor V Yosypiv (IV)

Section of Pediatric Nephrology, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA. iiosipi@tulane.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH